# ObsEva SA

ObsEva SA is a company headquartered in Plan-Les-Ouates, Switzerland.

## Company overview

- **Legal name:** ObsEva SA
- **Classification:** Company
- **Industry (SIC):** 2834 — Pharmaceutical Preparations
- **Headquarters:** Plan-Les-Ouates, Switzerland
- **Incorporated in:** Switzerland
- **Fiscal year end:** December 31
- **SEC CIK:** 0001685316

## About

ObsEva SA is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001685316, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2023-03-31, it reported annual revenue of USD 19,637,000; net income of USD -29,879,000; total assets of USD 16,544,000 for the fiscal period ended 2022-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2022 (period ended 2022-12-31)

- **Revenue:** $19.6M (USD 19,637,000)
- **Net income:** -$29.9M (USD -29,879,000)
- **Total assets:** $16.5M (USD 16,544,000)
- **Cash and equivalents:** $8.4M (USD 8,424,000)
- **Operating cash flow:** -$23.1M (USD -23,146,000)

### FY2021 (period ended 2021-12-31)

- **Revenue:** $0 (USD 0)
- **Net income:** -$58.4M (USD -58,377,000)
- **Total assets:** $89.0M (USD 88,991,000)
- **Cash and equivalents:** $54.7M (USD 54,734,000)
- **Operating cash flow:** -$70.3M (USD -70,304,000)

### FY2020 (period ended 2020-12-31)

- **Revenue:** $0 (USD 0)
- **Net income:** -$83.0M (USD -82,966,000)
- **Total assets:** $65.4M (USD 65,447,000)
- **Cash and equivalents:** $31.2M (USD 31,183,000)
- **Operating cash flow:** -$70.8M (USD -70,766,000)

### FY2019 (period ended 2019-12-31)

- **Revenue:** $0 (USD 0)
- **Net income:** -$108.8M (USD -108,790,000)
- **Total assets:** $103.9M (USD 103,943,000)
- **Cash and equivalents:** $69.4M (USD 69,370,000)
- **Operating cash flow:** -$90.6M (USD -90,611,000)

## Recent SEC filings

- Form SC 13D — filed 2023-04-17 — SC 13D
- Form 8-K — filed 2023-04-11 — period 2023-04-06 — 8-K
- Form 10-K — filed 2023-03-31 — period 2022-12-31 — 10-K
- Form 8-K — filed 2023-03-22 — period 2023-03-22 — 8-K
- Form 8-K — filed 2023-03-15 — period 2023-03-14 — 8-K
- Form 8-K — filed 2023-03-13 — period 2023-03-10 — 8-K
- Form 8-K — filed 2023-03-01 — period 2023-02-28 — 8-K
- Form 8-K — filed 2023-02-24 — period 2023-02-23 — 8-K
- Form 8-K — filed 2023-01-03 — period 2023-01-03 — 8-K
- Form 6-K — filed 2022-12-19 — period 2022-12-19 — 6-K
- Form 6-K — filed 2022-12-14 — period 2022-12-14 — 6-K
- Form 6-K — filed 2022-12-09 — period 2022-12-09 — 6-K

---

Updated: 2026-10-23T20:12:17Z

Canonical page: https://altss.com/profile/obseva-sa

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology